Medicare Enrolled

Dr. Yasaman Mohtasebi, M.D.

Endocrinology · Long Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1868 PACIFIC AVE, Long Beach, CA 90806
5625954718
In practice since 2008 (18 years)
NPI: 1962687889 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mohtasebi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohtasebi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mohtasebi

Dr. Yasaman Mohtasebi is an endocrinology specialist in Long Beach, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mohtasebi performed 595 Medicare services across 270 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mohtasebi received a total of $23,590 from 53 pharmaceutical and/or device companies across 1108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mohtasebi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 595 Medicare services $23,590 industry payments

Medicare Practice Summary

Medicare Utilization ↗
595
Medicare services
Bottom 46% in CA for endocrinology
270
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~33 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
359 $94 $264
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
81 $27 $75
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
65 $67 $158
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $60 $185
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
19 $123 $341
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
19 $38 $92
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,590
Total received (2018-2024)
Avg $3,370/year across 7 years
Top 12% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,108
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,590 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,630
2023
$5,179
2022
$5,185
2021
$3,505
2020
$1,760
2019
$1,689
2018
$1,643

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$510
Amgen Inc.
$405
Bayer Healthcare Pharmaceuticals Inc.
$370
CeQur Corporation
$328
Corcept Therapeutics
$320
Novo Nordisk Inc
$307
Dexcom, Inc.
$304
Abbott Laboratories
$280
SANOFI-AVENTIS U.S. LLC
$256
Tandem Diabetes Care, Inc.
$252
Madrigal Pharmaceuticals
$197
RECORDATI_RARE_DISEASES_INC.
$185
Boehringer Ingelheim Pharmaceuticals, Inc.
$150
ABBVIE INC.
$134
Insulet Corporation
$83
Kyowa Kirin, Inc.
$73
Radius Health, Inc.
$63
Antares Pharma, Inc.
$62
Neurocrine Biosciences, Inc.
$60
Mannkind Corporation
$59
Medtronic, Inc.
$54
Ascensia Diabetes Care Us Inc.
$49
Verity Pharmaceuticals Inc.
$44
Chiesi USA, Inc.
$29
Esperion Therapeutics, Inc.
$21
TheracosBio, LLC
$19
Alvogen Inc
$16
Top 3 companies account for 27.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$3,042
Novo Nordisk Inc
$1,994
Dexcom, Inc.
$1,963
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,590
Corcept Therapeutics
$1,257
Abbott Laboratories
$1,125
SANOFI-AVENTIS U.S. LLC
$959
Horizon Therapeutics plc
$843
Amgen Inc.
$822
CeQur Corporation
$819
Mannkind Corporation
$763
AstraZeneca Pharmaceuticals LP
$704
Bayer Healthcare Pharmaceuticals Inc.
$582
Bayer HealthCare Pharmaceuticals Inc.
$514
Merck Sharp & Dohme Corporation
$514
MannKind Corporation
$509
Bigfoot Biomedical Inc
$457
ABBVIE INC.
$397
Tandem Diabetes Care, Inc.
$358
Becton, Dickinson and Company
$351
Zealand Pharma US, Inc.
$343
Insulet Corporation
$335
Xeris Pharmaceuticals, Inc.
$333
Ultragenyx Pharmaceutical Inc.
$310
Medtronic, Inc.
$221
Ascensia Diabetes Care Us Inc.
$218
RECORDATI_RARE_DISEASES_INC.
$215
AbbVie Inc.
$203
Madrigal Pharmaceuticals
$197
Janssen Pharmaceuticals, Inc
$160
Antares Pharma, Inc.
$151
IBSA Pharma Inc.
$116
Kyowa Kirin, Inc.
$115
Embecta Corp.
$101
Medtronic MiniMed, Inc.
$92
Valeritas, Inc.
$90
AbbVie, Inc.
$82
Nevro Corp.
$77
Radius Health, Inc.
$75
Novartis Pharmaceuticals Corporation
$70
Esperion Therapeutics, Inc.
$68
Alexion Pharmaceuticals, Inc.
$67
Amryt Pharma Holdings Ltd
$66
Neurocrine Biosciences, Inc.
$60
LIFESCAN, INC.
$49
Verity Pharmaceuticals Inc.
$44
Aytu BioScience, Inc
$36
Chiesi USA, Inc.
$29
Supernus Pharmaceuticals, Inc.
$24
Averitas Pharma Inc.
$24
Intercept Pharmaceuticals, Inc.
$20
TheracosBio, LLC
$19
Alvogen Inc
$16
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD Nano · BD Nano 2nd Gen Pen Needle · Brenzavvy · CRYSVITA · CRYSViTA · CeQur Simplicity · Crysvita · Cryvista · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · ETERNA · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FIASP · FREESTYLE INSULINX · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LINZESS · LYUMJEV · Levemir · MINILINK TESTER · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NEXLETOL · Natesto · OCALIVA · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OTREXUP · Omnia · Omnipod · Otrexup · Ozempic · QUTENZA · RESMETIROM · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · Strensiq · Synthroid · TAGRISSO · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Victoza · Wegovy · XYOSTED · ZEGALOGUE · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Long Beach?
Compare endocrinologists in the Long Beach area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
284
Per 100K population
2.9
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mohtasebi is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mohtasebi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mohtasebi performed 359 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mohtasebi receive payments from pharmaceutical companies?
Yes. Dr. Mohtasebi received a total of $23,590 from 53 companies across 1,108 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohtasebi's costs compare to other endocrinologists in Long Beach?
Dr. Mohtasebi's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohtasebi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →